Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $30.78 billion
- Book Value:
- Revenue TTM:
- $241.81 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $8.33 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
AmerisourceBergen had its IPO on 1995-04-04 under the ticker symbol ABC.
The company operates in the Healthcare sector and Medical Distribution industry. AmerisourceBergen has a staff strength of 39,000 employees.
Shares of AmerisourceBergen opened at $150.85 at the start of the last trading session i.e. 2023-03-24.
The stocks traded within a range of $150.25 - $156.59, and closed at $156.41.
This is a +3.63% increase from the previous day's closing price.
A total volume of 1,155,883 shares were traded at the close of the day’s session.
In the last one week, shares of AmerisourceBergen have increased by +2.87%.
AmerisourceBergen's Key Ratios
AmerisourceBergen has a market cap of $30.78 billion, indicating a price to book ratio of 5.5793 and a price to sales ratio of 0.1405.
In the last 12-months AmerisourceBergen’s revenue was $241.81 billion with a gross profit of $8.33 billion and an EBITDA of $3.41 billion. The EBITDA ratio measures AmerisourceBergen's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, AmerisourceBergen’s operating margin was 1.12% while its return on assets stood at 2.94% with a return of equity of 50.2%.
In Q4, AmerisourceBergen’s quarterly earnings growth was a positive 9.4% while revenue growth was a positive 5.4%.
AmerisourceBergen’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $8.24 per share while it has a forward price to earnings multiple of 14.2045 and a PEG multiple of 1.5767. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AmerisourceBergen’s profitability.
AmerisourceBergen stock is trading at a EV to sales ratio of 0.1497 and a EV to EBITDA ratio of 11.4283. Its price to sales ratio in the trailing 12-months stood at 0.1405.
AmerisourceBergen stock pays annual dividends of $1.865 per share, indicating a yield of 1.27% and a payout ratio of 16.95%.
Balance sheet and cash flow metrics
- Total Assets
- $57.91 billion
- Total Liabilities
- $44.76 billion
- Operating Cash Flow
- Capital Expenditure
- $75.73 million
- Dividend Payout Ratio
AmerisourceBergen ended 2023 with $57.91 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $57.91 billion while shareholder equity stood at $-178131000.00.
AmerisourceBergen ended 2023 with $1.63 billion in deferred long-term liabilities, $44.76 billion in other current liabilities, 2942000.00 in common stock, $3.36 billion in retained earnings and $8.60 billion in goodwill. Its cash balance stood at $1.69 billion and cash and short-term investments were $1.69 billion. The company’s total short-term debt was $988,275,000 while long-term debt stood at $4.66 billion.
AmerisourceBergen’s total current assets stands at $40.71 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $18.71 billion compared to accounts payable of $41.76 billion and inventory worth $16.78 billion.
In 2023, AmerisourceBergen's operating cash flow was $-1511158000.00 while its capital expenditure stood at $75.73 million.
Comparatively, AmerisourceBergen paid $0.17 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
AmerisourceBergen stock is currently trading at $156.41 per share. It touched a 52-week high of $174.0934 and a 52-week low of $174.0934. Analysts tracking the stock have a 12-month average target price of $185.
Its 50-day moving average was $157.6 and 200-day moving average was $151.7 The short ratio stood at 2.1 indicating a short percent outstanding of 0%.
Around 1695.2% of the company’s stock are held by insiders while 7791.7% are held by institutions.
Frequently Asked Questions About AmerisourceBergen
Similar Industry Stocks (Medical Distribution)
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company’s International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.